{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:52:50Z","timestamp":1791928370795,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union\u2019s Seventh Framework Program","award":["267429"],"award-info":[{"award-number":["267429"]}]},{"name":"EraSysApp\/BMBF","award":["031A602A"],"award-info":[{"award-number":["031A602A"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.virusres.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T04:09:42Z","timestamp":1443240582000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Multi-scale model for hepatitis C viral load kinetics under treatment with direct acting antivirals"],"prefix":"10.1016","volume":"218","author":[{"given":"Diana","family":"Clausznitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Harnisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kaderali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2015.09.011_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2015.09.011_bib0010","first-page":"1","article-title":"The origin of hepatitis C virus. Hepatitis C virus: from molecular virology to antiviral therapy","volume":"369","author":"Simmonds","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.virusres.2015.09.011_bib0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nature Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.virusres.2015.09.011_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J. Hepatol."},{"issue":"5255","key":"10.1016\/j.virusres.2015.09.011_bib0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"Perelson","year":"1996","journal-title":"Science"},{"issue":"6510","key":"10.1016\/j.virusres.2015.09.011_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2015.09.011_bib0035","first-page":"S17","article-title":"Dynamics of HIV-1 and CD4+ lymphocytes in vivo","volume":"11","author":"Perelson","year":"1997","journal-title":"AIDS"},{"issue":"5386","key":"10.1016\/j.virusres.2015.09.011_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.virusres.2015.09.011_bib0045","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3851\/IMP2428","article-title":"Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?","volume":"17","author":"Chatterjee","year":"2012","journal-title":"Antiviral Ther."},{"issue":"1","key":"10.1016\/j.virusres.2015.09.011_bib0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.22586","article-title":"Modeling complex decay profiles of hepatitis b virus during antiviral therapy","volume":"49","author":"Dahari","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.virusres.2015.09.011_bib0055","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/jhep.2001.28509","article-title":"Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed","volume":"34","author":"Lewin","year":"2001","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.virusres.2015.09.011_bib0060","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1073\/pnas.93.9.4398","article-title":"Viral dynamics in hepatitis B virus infection","volume":"93","author":"Nowak","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.virusres.2015.09.011_bib0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1286-4579(02)01603-9","article-title":"Dynamics of hepatitis B virus infection","volume":"4","author":"Ribeiro","year":"2002","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.virusres.2015.09.011_bib0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nm.3103","article-title":"Rapid host immune response and viral dynamics in herpes simplex virus-2 infection","volume":"19","author":"Schiffer","year":"2013","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.virusres.2015.09.011_bib0075","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.01623-05","article-title":"Kinetics of influenza A virus infection in humans","volume":"80","author":"Baccam","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2015.09.011_bib0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jtbi.2004.08.001","article-title":"A simple cellular automaton model for influenza A viral infections","volume":"232","author":"Beauchemin","year":"2005","journal-title":"J. Theor. Biol."},{"issue":"6","key":"10.1016\/j.virusres.2015.09.011_bib0085","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1128\/JVI.01318-10","article-title":"Population modeling of influenza a\/h1n1 virus kinetics and symptom dynamics","volume":"85","author":"Canini","year":"2011","journal-title":"J. Virol."},{"issue":"42","key":"10.1016\/j.virusres.2015.09.011_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1098\/rsif.2009.0067","article-title":"Towards a quantitative understanding of the within-host dynamics of influenza A infections","volume":"7","author":"Handel","year":"2010","journal-title":"J. R. Soc. Interface"},{"issue":"4","key":"10.1016\/j.virusres.2015.09.011_bib0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/wsbm.129","article-title":"Influenza A virus infection kinetics: quantitative data and model","volume":"3","author":"Smith","year":"2011","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"6","key":"10.1016\/j.virusres.2015.09.011_bib0100","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/clpt.2010.35","article-title":"A comprehensive hepatitis C viral kinetic model explaining cure","volume":"87","author":"Snoeck","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.virusres.2015.09.011_bib0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/135965350801300711","article-title":"A hepatitis C viral kinetic model that allows for time-varying drug effectiveness","volume":"13","author":"Shudo","year":"2008","journal-title":"Antiviral Ther."},{"issue":"5","key":"10.1016\/j.virusres.2015.09.011_bib0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.21136","article-title":"Pharmacodynamics of PEG-IFN alpha differentiate HIV\/HCV coinfected sustained virological responders from nonresponders","volume":"43","author":"Talal","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.virusres.2015.09.011_bib0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0163-7258(82)90051-1","article-title":"Kinetics of pharmacologic response","volume":"16","author":"Holford","year":"1982","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.virusres.2015.09.011_bib0120","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1073\/pnas.1203110110","article-title":"Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life","volume":"110","author":"Guedj","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.virusres.2015.09.011_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002959","article-title":"Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model","volume":"9","author":"Rong","year":"2013","journal-title":"PloS Comput. Biol."},{"issue":"1","key":"10.1016\/j.virusres.2015.09.011_bib0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mbs.2013.04.012","article-title":"Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents","volume":"245","author":"Rong","year":"2013","journal-title":"Math. Biosci."},{"issue":"8","key":"10.1016\/j.virusres.2015.09.011_bib0135","doi-asserted-by":"crossref","first-page":"e1003561","DOI":"10.1371\/journal.ppat.1003561","article-title":"Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle","volume":"9","author":"Binder","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.virusres.2015.09.011_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20032","article-title":"Structural biology of hepatitis C virus","volume":"39","author":"Penin","year":"2004","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.virusres.2015.09.011_bib0145","first-page":"22732","article-title":"Hepatitis C virus: assembly and release of virus particles","volume":"28","author":"Jones","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.virusres.2015.09.011_bib0150","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1128\/JVI.03404-13","article-title":"Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside-caught in the web","volume":"88","author":"Chatel-Chaix","year":"2014","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2015.09.011_bib0155","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/hep.24609","article-title":"Multiple ascending dose study of BMS-790052: a nonstructural protein 5a replication complex inhibitor, in patients infected with hepatitis C virus genotype 1","volume":"54","author":"Nettles","year":"2011","journal-title":"Hepatology"},{"issue":"7294","key":"10.1016\/j.virusres.2015.09.011_bib0160","doi-asserted-by":"crossref","first-page":"96-U108","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.virusres.2015.09.011_bib0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archinte.1961.03620030023003","article-title":"Lifespan of liver cells. Autoradiographic study using tritiated thymidine in normal, cirrhotic, and partially hepatectomized rats","volume":"107","author":"Macdonald","year":"1961","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.virusres.2015.09.011_bib0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1440-1711.2002.01063.x","article-title":"Hepatoimmunology: a perspective","volume":"80","author":"Mackay","year":"2002","journal-title":"Immunol. Cell Biol."},{"issue":"5","key":"10.1016\/j.virusres.2015.09.011_bib0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10928-014-9363-3","article-title":"Viral kinetic modeling: state of the art","volume":"41","author":"Canini","year":"2014","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"11","key":"10.1016\/j.virusres.2015.09.011_bib0180","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3748\/wjg.v20.i11.2777","article-title":"Role of macrophages and monocytes in hepatitis C virus infections","volume":"20","author":"Revie","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.virusres.2015.09.011_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/lt.20572","article-title":"Kinetics of hepatitis C virus reinfection after liver transplantation","volume":"12","author":"Powers","year":"2006","journal-title":"Liver Transplant."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215300666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215300666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T09:17:47Z","timestamp":1653211067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170215300666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"alternative-id":["S0168170215300666"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2015.09.011","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-scale model for hepatitis C viral load kinetics under treatment with direct acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}